Stocks and Investing
Stocks and Investing
Thu, August 17, 2017
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
Wed, August 16, 2017
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
Terence Flynn Upgraded (BIIB) to Strong Buy on, Aug 16th, 2017
Terence Flynn of Goldman Sachs, Upgraded "Biogen Inc." (BIIB) to Strong Buy on, Aug 16th, 2017.
Terence has made no other calls on BIIB in the last 4 months.
There are 5 other peers that have a rating on BIIB. Out of the 5 peers that are also analyzing BIIB, 4 agree with Terence's Rating of Hold. Following are those relevant analyst calls for the last 4 months
- Carter Gould of "UBS" Maintained at Hold with Increased Target to $285 on, Wednesday, July 26th, 2017
- Jeffrey Silber of "BMO Capital" Maintained at Hold with Decreased Target to $285 on, Wednesday, July 26th, 2017
- Matthew Harrison of "Morgan Stanley" Maintained at Hold with Increased Target to $311 on, Wednesday, July 26th, 2017
- Eun Yang of "Jefferies" Initiated at Hold and Held Target at $310 on, Tuesday, July 11th, 2017
This is the rating of the analyst that currently disagrees with Terence
- Andrew Peters of "Deutsche Bank" Initiated at Strong Buy and Held Target at $315 on, Friday, June 23rd, 2017
Contributing Sources